<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1665-1146</journal-id>
<journal-title><![CDATA[Boletín médico del Hospital Infantil de México]]></journal-title>
<abbrev-journal-title><![CDATA[Bol. Med. Hosp. Infant. Mex.]]></abbrev-journal-title>
<issn>1665-1146</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1665-11462016000100047</article-id>
<article-id pub-id-type="doi">10.1016/j.bmhimx.2015.12.002</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Epidemiology of Epstein-Barr virus-associated pediatric lymphomas from Argentina]]></article-title>
<article-title xml:lang="es"><![CDATA[Epidemiología de linfomas pediátricos asociados con el virus de Epstein-Barr en Argentina]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chabay]]></surname>
<given-names><![CDATA[Paola]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Preciado]]></surname>
<given-names><![CDATA[María Victoria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Hospital de Niños Ricardo Gutiérrez División Patología Laboratorio de Biología Molecular]]></institution>
<addr-line><![CDATA[Buenos Aires ]]></addr-line>
<country>Argentina</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Consejo Nacional de Investigaciones Científicas y Técnicas Gobierno de la Ciudad de Buenos Aires Instituto Multidisciplinario de Investigación en Patologías Pediátricas]]></institution>
<addr-line><![CDATA[Buenos Aires ]]></addr-line>
<country>Argentina</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2016</year>
</pub-date>
<volume>73</volume>
<numero>1</numero>
<fpage>47</fpage>
<lpage>54</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1665-11462016000100047&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1665-11462016000100047&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1665-11462016000100047&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[More than 90% of the population is infected by Epstein-Barr virus (EBV), which has sophisticatedly evolved to survive silently in B cells for the life of infected individuals. However, if the virus-host balance is disturbed, latent EBV infection could be associated with several lymphomas. The age at primary infection varies substantially worldwide, and exposure to EBV is likely to be due to socioeconomic factors. In Argentina, EBV infection is mostly subclinical and 90% of patients are seropositive by the age of 3 years; therefore, its epidemiological characteristics resemble those of an underdeveloped or developing population. EBV-positive Hodgkin lymphoma (HL) in young adults from developed populations has been attributed to delayed primary EBV infection as suggested by the association with recent mononucleosis development. EBV-associated Burkitt lymphoma and Hodgkin lymphoma in children from Argentina display frequencies similar to those observed in developed countries, whereas EBV presence in pediatric diffuse large B-cell lymphoma is slightly increased compared to those populations. However, EBV presence is statistically associated particularly with patients &lt; 10 years of age in all three entities. Therefore, a relationship between low age of EBV seroconversion and B-cell lymphoma development risk could be suggested in children from Argentina.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Más del 90% de la población se encuentra infectada con el virus de Epstein-Barr (VEB), que ha evolucionado sofisticadamente para sobrevivir de por vida de manera silenciosa en las células B de individuos infectados. Sin embargo, si el balance entre el virus y el huésped se altera, la infección latente por VEB se podría asociar con linfomas severos. La edad de la infección primaria varía sustancialmente a escala global, y la exposición al VEB al parecer se relaciona con factores socioeconómicos. En Argentina, la infección por VEB es mayormente subclínica, y el 90% de los pacientes son seropositivos a la edad de 3 años. Por lo tanto, las características epidemiológicas se asemejan a aquellas de una población subdesarrollada o en vías de desarrollo. El linfoma de Hodgkin (LH) positivo para VEB en adultos jóvenes se ha atribuido a una infección por VEB tardía en economías desarrolladas, como lo sugiere la asociación con el desarrollo de mononucleosis. En Argentina, el linfoma de Burkitt y el linfoma de Hodgkin asociados con VEB en niños presentan frecuencias similares a las observadas en países desarrollados, mientras que la presencia de VEB en el linfoma difuso de células B pediátrico se encuentra con un ligero aumento comparado con estas poblaciones. Sin embargo, la presencia de VEB en los tres padecimientos se asocia estadísticamente, en particular, con pacientes menores de 10 años. Por ello, se podría sugerir una la relación entre la menor edad de seroconversión y el riesgo de desarrollo de linfoma de células B en niños de Argentina.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Epstein-Barr virus]]></kwd>
<kwd lng="en"><![CDATA[Hodgkin lymphoma]]></kwd>
<kwd lng="en"><![CDATA[Burkitt lymphoma]]></kwd>
<kwd lng="en"><![CDATA[Diffuse large B-cell lymphoma]]></kwd>
<kwd lng="en"><![CDATA[Pediatric lymphoma]]></kwd>
<kwd lng="es"><![CDATA[Virus de Epstein-Barr]]></kwd>
<kwd lng="es"><![CDATA[Linfoma de Hodgkin]]></kwd>
<kwd lng="es"><![CDATA[Linfoma de Burkitt]]></kwd>
<kwd lng="es"><![CDATA[Linfoma difuso de células B]]></kwd>
<kwd lng="es"><![CDATA[Linfoma pediátrico]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ok]]></surname>
<given-names><![CDATA[C.Y]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[K.H]]></given-names>
</name>
</person-group>
<source><![CDATA[Exp Mol Med]]></source>
<year>2015</year>
<volume>47</volume>
<page-range>e132</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The immunology of Epstein-Barr virus-induced disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[G.S]]></given-names>
</name>
<name>
<surname><![CDATA[Long]]></surname>
<given-names><![CDATA[H.M]]></given-names>
</name>
<name>
<surname><![CDATA[Brooks]]></surname>
<given-names><![CDATA[J.M]]></given-names>
</name>
<name>
<surname><![CDATA[Rickinson]]></surname>
<given-names><![CDATA[A.B]]></given-names>
</name>
<name>
<surname><![CDATA[Hislop]]></surname>
<given-names><![CDATA[A.D]]></given-names>
</name>
</person-group>
<source><![CDATA[Annu Rev Immunol]]></source>
<year>2015</year>
<volume>33</volume>
<page-range>787-821</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epstein-Barr virus latent genes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[M.S]]></given-names>
</name>
<name>
<surname><![CDATA[Kieff]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Exp Mol Med]]></source>
<year>2015</year>
<volume>47</volume>
<page-range>e131</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Progress and problems in understanding and managing primary Epstein-Barr virus infections]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Odumade]]></surname>
<given-names><![CDATA[O.A]]></given-names>
</name>
<name>
<surname><![CDATA[Hogquist]]></surname>
<given-names><![CDATA[K.A]]></given-names>
</name>
<name>
<surname><![CDATA[H.H]]></surname>
<given-names><![CDATA[Balfour Jr.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Microbiol Rev]]></source>
<year>2011</year>
<volume>24</volume>
<page-range>193-209</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[J.L]]></given-names>
</name>
<name>
<surname><![CDATA[Glaser]]></surname>
<given-names><![CDATA[S.L]]></given-names>
</name>
</person-group>
<source><![CDATA[Crit Rev Oncol Hematol]]></source>
<year>2000</year>
<volume>34</volume>
<page-range>27-53</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Infectious mononucleosis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balfour Jr]]></surname>
<given-names><![CDATA[H.H]]></given-names>
</name>
<name>
<surname><![CDATA[Dunmire]]></surname>
<given-names><![CDATA[S.K]]></given-names>
</name>
<name>
<surname><![CDATA[Hogquist]]></surname>
<given-names><![CDATA[K.A]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Transl Immunology]]></source>
<year>2015</year>
<volume>4</volume>
<page-range>e33</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rickinson]]></surname>
<given-names><![CDATA[A.B]]></given-names>
</name>
<name>
<surname><![CDATA[Long]]></surname>
<given-names><![CDATA[H.M]]></given-names>
</name>
<name>
<surname><![CDATA[Palendira]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Münz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hislop]]></surname>
<given-names><![CDATA[A.D]]></given-names>
</name>
</person-group>
<source><![CDATA[Trends Immunol]]></source>
<year>2014</year>
<volume>35</volume>
<page-range>159-69</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jayasooriya]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[de Silva]]></surname>
<given-names><![CDATA[T.I]]></given-names>
</name>
<name>
<surname><![CDATA[Njie-jobe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sanyang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Leese]]></surname>
<given-names><![CDATA[A.M]]></given-names>
</name>
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[A.I]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS Pathog]]></source>
<year>2015</year>
<volume>11</volume>
<page-range>e1004746</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Role for early-differentiated natural killer cells in infectious mononucleosis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Azzi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lünemann]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Murer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ueda]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Béziat]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Malmberg]]></surname>
<given-names><![CDATA[K.J]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>2014</year>
<volume>124</volume>
<page-range>2533-43</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[EBV primary infection in childhood and its relation to B-cell lymphoma development: a mini-review from a developing region]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chabay]]></surname>
<given-names><![CDATA[P.A]]></given-names>
</name>
<name>
<surname><![CDATA[Preciado]]></surname>
<given-names><![CDATA[M.V]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Cancer]]></source>
<year>2013</year>
<volume>133</volume>
<page-range>1286-92</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hjalgrim]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Engels]]></surname>
<given-names><![CDATA[E.A]]></given-names>
</name>
</person-group>
<source><![CDATA[J Intern Med]]></source>
<year>2008</year>
<volume>264</volume>
<page-range>537-48</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hjalgrim]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Smedby]]></surname>
<given-names><![CDATA[K.E]]></given-names>
</name>
<name>
<surname><![CDATA[Rostgaard]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Molin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hamilton-Dutoit]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[E.T]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Res]]></source>
<year>2007</year>
<volume>67</volume>
<page-range>2382-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bertrand]]></surname>
<given-names><![CDATA[K.A]]></given-names>
</name>
<name>
<surname><![CDATA[Birmann]]></surname>
<given-names><![CDATA[B.M]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[E.T]]></given-names>
</name>
<name>
<surname><![CDATA[Spiegelman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Aster]]></surname>
<given-names><![CDATA[J.C]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[S.M]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>2010</year>
<volume>116</volume>
<page-range>3547-53</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Risk of Hodgkin&amp;apos;s disease and other cancers after infectious mononucleosis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hjalgrim]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Askling]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sørensen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Madsen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rosdahl]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Storm]]></surname>
<given-names><![CDATA[H.H]]></given-names>
</name>
</person-group>
<source><![CDATA[J Natl Cancer Inst]]></source>
<year>2000</year>
<volume>92</volume>
<page-range>1522-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cader]]></surname>
<given-names><![CDATA[F.Z]]></given-names>
</name>
<name>
<surname><![CDATA[Kearns]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vockerodt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Treat Rev]]></source>
<year>2010</year>
<volume>36</volume>
<page-range>348-53</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The biology of Hodgkin&amp;apos;s lymphoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Küppers]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Rev Cancer]]></source>
<year>2009</year>
<volume>9</volume>
<page-range>15-27</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[L.S]]></given-names>
</name>
</person-group>
<source><![CDATA[Hodgkin's lymphoma: molecular pathogenesis and the contribution of the Epstein-Barr virus. Epstein-Barr Virus]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Norfolk ]]></publisher-loc>
<publisher-name><![CDATA[Caiser Academic Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Classical Hodgkin's lymphoma arising in different host's conditions pathobiology parameters, therapeutic options, and outcome]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carbone]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Spina]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gloghini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tirelli]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Hematol]]></source>
<year>2011</year>
<volume>86</volume>
<page-range>170-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comparison of Epstein-Barr virus presence in Hodgkin lymphoma in pediatric versus adult Argentine patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Matteo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Barón]]></surname>
<given-names><![CDATA[A.V]]></given-names>
</name>
<name>
<surname><![CDATA[Chabay]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Porta]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Dragosky]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Preciado]]></surname>
<given-names><![CDATA[M.V]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Pathol Lab Med]]></source>
<year>2003</year>
<volume>127</volume>
<page-range>1325-9</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin&amp;apos;s disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Preciado]]></surname>
<given-names><![CDATA[M.V]]></given-names>
</name>
<name>
<surname><![CDATA[De Matteo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Diez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Menárguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Grinstein]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>1995</year>
<volume>86</volume>
<page-range>3922-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chabay]]></surname>
<given-names><![CDATA[P.A]]></given-names>
</name>
<name>
<surname><![CDATA[Barros]]></surname>
<given-names><![CDATA[M.H]]></given-names>
</name>
<name>
<surname><![CDATA[Hassan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[De Matteo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rey]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Carrico]]></surname>
<given-names><![CDATA[M.K]]></given-names>
</name>
</person-group>
<source><![CDATA[J Pediatr Hematol Oncol]]></source>
<year>2008</year>
<volume>30</volume>
<page-range>285-91</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barros]]></surname>
<given-names><![CDATA[M.H]]></given-names>
</name>
<name>
<surname><![CDATA[Vera-Lozada]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[F.A]]></given-names>
</name>
<name>
<surname><![CDATA[Niedobitek]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hassan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Cancer]]></source>
<year>2012</year>
<volume>131</volume>
<page-range>1142-52</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barros]]></surname>
<given-names><![CDATA[M.H]]></given-names>
</name>
<name>
<surname><![CDATA[Hassan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Niedobitek]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Cancer Res]]></source>
<year>2012</year>
<volume>18</volume>
<page-range>3762-71</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Araujo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bittencourt]]></surname>
<given-names><![CDATA[A.L]]></given-names>
</name>
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[H.S]]></given-names>
</name>
<name>
<surname><![CDATA[Netto]]></surname>
<given-names><![CDATA[E.M]]></given-names>
</name>
<name>
<surname><![CDATA[Mendonça]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Foss]]></surname>
<given-names><![CDATA[H.D]]></given-names>
</name>
</person-group>
<source><![CDATA[Virchows Arch]]></source>
<year>2006</year>
<volume>449</volume>
<page-range>315-9</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quintanilla-Martínez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gamboa-Domínquez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gamez-Ledesma]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Angeles-Angeles]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mohar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Mod Pathol]]></source>
<year>1995</year>
<volume>8</volume>
<page-range>675-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[K.L]]></given-names>
</name>
<name>
<surname><![CDATA[Albújar]]></surname>
<given-names><![CDATA[P.F]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Y.Y]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[R.M]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[L.M]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>1993</year>
<volume>81</volume>
<page-range>496-501</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Human viral oncogenesis: a cancer hallmarks analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mesri]]></surname>
<given-names><![CDATA[E.A]]></given-names>
</name>
<name>
<surname><![CDATA[Feitelson]]></surname>
<given-names><![CDATA[M.A]]></given-names>
</name>
<name>
<surname><![CDATA[Munger]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Cell Host Microbe]]></source>
<year>2014</year>
<volume>15</volume>
<page-range>266-82</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancao]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Altmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jungnickel]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hammerschmidt]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>2005</year>
<volume>106</volume>
<page-range>4339-44</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancao]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hammerschmidt]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>2007</year>
<volume>110</volume>
<page-range>3715-21</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The pathogenesis of Epstein-Barr virus persistent infection]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thorley-Lawson]]></surname>
<given-names><![CDATA[D.A]]></given-names>
</name>
<name>
<surname><![CDATA[Hawkins]]></surname>
<given-names><![CDATA[J.B]]></given-names>
</name>
<name>
<surname><![CDATA[Tracy]]></surname>
<given-names><![CDATA[S.I]]></given-names>
</name>
<name>
<surname><![CDATA[Shapiro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Opin Virol]]></source>
<year>2013</year>
<volume>3</volume>
<page-range>227-32</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epstein-Barr virus and Burkitt lymphoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brady]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[MacArthur]]></surname>
<given-names><![CDATA[G.J]]></given-names>
</name>
<name>
<surname><![CDATA[Farrell]]></surname>
<given-names><![CDATA[P.J]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Pathol]]></source>
<year>2007</year>
<volume>60</volume>
<page-range>1397-402</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[G.L]]></given-names>
</name>
<name>
<surname><![CDATA[Rickinson]]></surname>
<given-names><![CDATA[A.B]]></given-names>
</name>
</person-group>
<source><![CDATA[Hematology Am Soc Hematol Educ Program]]></source>
<year>2007</year>
<page-range>277-84</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rowe]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[G.L]]></given-names>
</name>
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[A.I]]></given-names>
</name>
<name>
<surname><![CDATA[Rickinson]]></surname>
<given-names><![CDATA[A.B]]></given-names>
</name>
</person-group>
<source><![CDATA[Semin Cancer Biol]]></source>
<year>2009</year>
<volume>19</volume>
<page-range>377-88</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epstein-Barr virus (EBV) association and latency profile in pediatric Burkitt's lymphoma: experience of a single institution in Argentina]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lara]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[De Matteo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Aversa]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Preciado]]></surname>
<given-names><![CDATA[M.V]]></given-names>
</name>
<name>
<surname><![CDATA[Chabay]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[J Med Virol]]></source>
<year>2014</year>
<volume>86</volume>
<page-range>845-50</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Queiroga]]></surname>
<given-names><![CDATA[E.M]]></given-names>
</name>
<name>
<surname><![CDATA[Gualco]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[L.M]]></given-names>
</name>
<name>
<surname><![CDATA[Dittmer]]></surname>
<given-names><![CDATA[D.P]]></given-names>
</name>
<name>
<surname><![CDATA[Araujo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Klumb]]></surname>
<given-names><![CDATA[C.E]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Clin Pathol]]></source>
<year>2008</year>
<volume>130</volume>
<page-range>946-56</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Promiscuous expression of Epstein-Barr virus genes in Burkitt&amp;apos;s lymphoma from the central African country Malawi]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xue]]></surname>
<given-names><![CDATA[S.A]]></given-names>
</name>
<name>
<surname><![CDATA[Labrecque]]></surname>
<given-names><![CDATA[L.G]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[Q.L]]></given-names>
</name>
<name>
<surname><![CDATA[Ong]]></surname>
<given-names><![CDATA[S.K]]></given-names>
</name>
<name>
<surname><![CDATA[Lampert]]></surname>
<given-names><![CDATA[I.A]]></given-names>
</name>
<name>
<surname><![CDATA[Kazembe]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Cancer]]></source>
<year>2002</year>
<volume>99</volume>
<page-range>635-43</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sehn]]></surname>
<given-names><![CDATA[L.H]]></given-names>
</name>
<name>
<surname><![CDATA[Gascoyne]]></surname>
<given-names><![CDATA[R.D]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>2015</year>
<volume>125</volume>
<page-range>22-32</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="book">
<collab>Health Organization World</collab>
<source><![CDATA[WHO classification of tumours of haematopoietic and lymphoid tissues]]></source>
<year>2008</year>
<publisher-loc><![CDATA[Lyon ]]></publisher-loc>
<publisher-name><![CDATA[WHO Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hong]]></surname>
<given-names><![CDATA[J.Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yoon]]></surname>
<given-names><![CDATA[D.H]]></given-names>
</name>
<name>
<surname><![CDATA[Suh]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Huh]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Do]]></surname>
<given-names><![CDATA[I.G]]></given-names>
</name>
<name>
<surname><![CDATA[Sohn]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Oncol]]></source>
<year>2015</year>
<volume>26</volume>
<page-range>548-55</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Narbaitz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Metrebian]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[De Matteo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Preciado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chabay]]></surname>
<given-names><![CDATA[P.A]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Cancer]]></source>
<year>2014</year>
<volume>135</volume>
<page-range>2816-24</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Malignant hematologic diseases in adolescents and young adults]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wood]]></surname>
<given-names><![CDATA[W.A]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[S.J]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>2011</year>
<volume>117</volume>
<page-range>5803-15</page-range></nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[De Matteo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Narbaitz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carreño]]></surname>
<given-names><![CDATA[F.A]]></given-names>
</name>
<name>
<surname><![CDATA[Preciado]]></surname>
<given-names><![CDATA[M.V]]></given-names>
</name>
<name>
<surname><![CDATA[Chabay]]></surname>
<given-names><![CDATA[P.A]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Cancer]]></source>
<year>2013</year>
<volume>132</volume>
<page-range>1572-80</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cool]]></surname>
<given-names><![CDATA[C.D]]></given-names>
</name>
</person-group>
<source><![CDATA[Hum Pathol]]></source>
<year>1997</year>
<volume>28</volume>
<page-range>1026-33</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tumwine]]></surname>
<given-names><![CDATA[L.K]]></given-names>
</name>
<name>
<surname><![CDATA[Orem]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kerchan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Byarugaba]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Pileri]]></surname>
<given-names><![CDATA[S.A]]></given-names>
</name>
</person-group>
<source><![CDATA[Infect Agent Cancer]]></source>
<year>2010</year>
<volume>5</volume>
<page-range>12</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly a comparative analysis of a Mexican and a German population]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hofscheier]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ponciano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bonzheim]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Adam]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lome-Maldonado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Vela]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Mod Pathol]]></source>
<year>2011</year>
<volume>24</volume>
<page-range>1046-54</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Age related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group a study of 96 patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oyama]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Yamamoto]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Asano]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Oshiro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Suzuki]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kagami]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Cancer Res]]></source>
<year>2007</year>
<volume>13</volume>
<page-range>5124-32</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Niedobitek]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Agathanggelou]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rowe]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[E.L]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[D.B]]></given-names>
</name>
<name>
<surname><![CDATA[Turyaguma]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>1995</year>
<volume>86</volume>
<page-range>659-65</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[J.J]]></given-names>
</name>
<name>
<surname><![CDATA[Beltran]]></surname>
<given-names><![CDATA[B.E]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[R.N]]></given-names>
</name>
<name>
<surname><![CDATA[Paydas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Winer]]></surname>
<given-names><![CDATA[E.S]]></given-names>
</name>
<name>
<surname><![CDATA[Butera]]></surname>
<given-names><![CDATA[J.N]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncologist]]></source>
<year>2011</year>
<volume>16</volume>
<page-range>87-96</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Role of human natural killer cells during Epstein-Barr virus infection]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Münz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Crit Rev Immunol]]></source>
<year>2014</year>
<volume>34</volume>
<page-range>501-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
